Cell No. : Cell Name
RCB1928 : KG-1a
update : 2024/08/14
|
| Comment | Human cell line derived from acute myelogenous leukemia. The variant subline of KG-1(RCB1166) cell line. TKG0402 (Deposited from Tohoku Univ.). |
| Comment from the depositor | |
| Terms and conditions | There is no restriction regarding use for basic researches. In relation to commercial use and use for patent filing, first of all please contact the RIKEN BRC. |
| Remarks | |
| Order Form |
Order Form(C-0005.pdf)
MTA(C-0007.pdf)
MTA(C-0007p.pdf)
|
|
Regarding MTA between user institutions and RIKEN BRC, there are two kinds of MTA, not-for-profit academic purpose (C-XXXX) and for-profit research purpose (C-XXXXp) , depending on the sort of user institutions and the purposes of use. Please use an appropriate MTA(to see). In relation to commercial use and use for patent filing, first of all Please contact RIKEN BRC (cellbank.brc@riken.jp).
|
|
|
Basic information
|
Depositor |
Obinata, Masuo
|
| Originator |
Koeffler,H.P. & Golde,D,W.
|
| Year of deposit |
2004
|
| Original cell |
TKG0402
|
| Animal |
_human
< Mammals
|
| Genus |
Homo
|
| Species |
sapiens
|
| Gender |
Male
|
| Age at sampling |
59 years
|
| Tissue |
bone marrow
|
| Disease name |
acute myelogenous leukemia
|
| Classification |
cancer
|
| History |
Cell Resource Center for Biomedical Research, Tohoku University（TKG0402）
|
|
Lifespan |
infinite
|
| Morphology |
lymphocyte-like
|
| Cellosaurus(Expasy) |
CVCL_1824
|
|
| |
deposit info |
lot info |
|
Medium |
Medium List |
|
Culture type |
|
Suspension cells
|
| Culture method |
|
浮遊細胞の培養に関する一般的な注意(Japanese)
|
| Culture medium |
|
RPMI1640 + 10% FBS
|
| Antibiotics |
|
Free
|
Culture information
|
Passage ratio |
|
1 : 8 split
|
| SC frequency |
|
Subculture : 2 times/week
|
| Temperature |
|
37
℃
|
| CO2 concentration |
|
5
%
|
| Freeze medium |
|
Medium + 10% DMSO
|
| Freezing method |
|
Slow freezing
|
| Mycoplasma/Acholeplasma |
|
(-)
|
| Virus (HIV) |
|
Undetected
|
| Virus (HTLV-1) |
|
(-)
|
| Isozyme |
|
LD, NP
|
| STR(human) |
|
OK
|
| Reference information |
Reference |
3
|
| User's Publication |
10
|
| User's Publication |
|
21650
Matsuo H, Inagami A, Ito Y, Ito N, Iyoda S, Harata Y, Higashitani M, Shoji K, Tanaka M, Noura M, Mikami T, Kato I, Takita J, Nakahata T, Adachi S.
Parbendazole as a promising drug for inducing differentiation of acute myeloid leukemia cells with various subtypes.
Commun Biol
2024
7(1):123
PubMed ID: 38267545
DOI: 10.1038/s42003-024-05811-8
|
|
19941
Dong X, Xue S, Chen C, Jiang Z, Wu X, Wang W.
MYCT-1 Gene Expression in Patients with Gastric Cancer: an Ex Vivo Study
Appl Biochem Biotechnol
2023
Dec 19
PubMed ID: 38112991
DOI: 10.1007/s12010-023-04754-w
|
|
21364
Yamanaka S, Furihata H, Yanagihara Y, Taya A, Nagasaka T, Usui M, Nagaoka K, Shoya Y, Nishino K, Yoshida S, Kosako H, Tanokura M, Miyakawa T, Imai Y, Shibata N, Sawasaki T.
Lenalidomide derivatives and proteolysis-targeting chimeras for controlling neosubstrate degradation.
Nat Commun
2023
14(1):4683
PubMed ID: 37596276
DOI: 10.1038/s41467-023-40385-9
|
|
16840
Sameh A. Mohammed, Yasuhiro Kimura, Yuhki Toku, Yang Ju
Bioengineered PLEKHA7 nanodelivery regularly induces behavior alteration and growth retardation of acute myeloid leukemia
Biomaterials and Biosystems
2022
6:100045
DOI: 10.1016/j.bbiosy.2022.100045
|
|
20347
Katayama K, Nishihata A.
RSK inhibition induces apoptosis by downregulating protein synthesis in a variety of acute myeloid leukemia cell lines.
Biol Pharm Bull
2021
PubMed ID: 34602526
DOI: 10.1248/bpb.b21-00531
|
|
20437
Mahara A, Kitagawa K, Otaka A, Nakaoki T, Ishihara K, Yamaoka T.
Impact of REDV peptide density and its linker structure on the capture, movement, and adhesion of flowing endothelial progenitor cells in microfluidic devices.
Mater Sci Eng C Mater Biol Appl
2021
129:112381
PubMed ID: 34579900
DOI: 10.1016/j.msec.2021.112381
|
|
16209
Takeshi Ueda, Akinori Kanai, Akiyoshi Komuro, Hisayuki Amano, Kazushige Ota, Masahiko Honda, Masahito Kawazu, Hitoshi Okada
KDM4B promotes acute myeloid leukemia associated with AML1-ETO by regulating chromatin accessibility
FASEB Bioadv
2021
3(12):1020-1033
PubMed ID: 34938963
DOI: 10.1096/fba.2021-00030
|
|
13354
Noura M, Morita K, Kiyose H, Matsuo H, Nishinaka-Arai Y, Kurokawa M, Kamikubo Y, Adachi S.
Pivotal role of DPYSL2A in KLF4-mediated monocytic differentiation of acute myeloid leukemia cells.
Sci Rep
2020
PubMed ID: 33219287
DOI: 10.1038/s41598-020-76951-0
|
|
13842
Hsieh HY, Jia W, Jin ZC, Kidoya H, Takakura N.
High expression of PSF1 promotes drug resistance and cell cycle transit in leukemia cells
Cancer Sci
2020
111(7):2400-2412
PubMed ID: 32391593
DOI: 10.1111/cas.14452
|
|
6132
Naito H, Kidoya H, Sato Y, Takakura N.
Induction and expression of anti-angiogenic vasohibins in the hematopoietic stem/progenitor cell population.
J Biochem
2009
145(5):653-9
PubMed ID: 19179360
DOI: 10.1093/jb/mvp021
|
Back
Top
CELL BANK Website